Literature DB >> 32142481

United States liver allocation.

Julie K Heimbach1.   

Abstract

PURPOSE OF REVIEW: The current review discusses the system of liver allocation in the United States, the adoption of the national liver review board (NLRB), and the pending major change to the system of distribution (acuity circle model). RECENT
FINDINGS: The system of liver allocation in the United States is based on the model for end-stage liver disease (MELD) score, a formula which uses commonly available tests (international normalized ratio, bilirubin, creatinine, and recently, sodium) prioritizes candidates on the waitlist according to likelihood of death without access to transplant. This review provides an overview of modifications to MELD allocation and well as a summary of the benefits and weaknesses. The review also details the pending major revision to the distribution of liver allografts, which attempts to reduce the geographic disparity in access by sharing across a broader geographic area. Finally, the review describes the implementation of the NLRB, which replaced the previous system in May 2019.
SUMMARY: The system of liver allocation and distribution in the United States has been subject to ongoing optimization, though the recent adoption of the NLRB, and pending change to distribution will significantly impact the system with the goal of reducing geographic disparity.

Entities:  

Mesh:

Year:  2020        PMID: 32142481     DOI: 10.1097/MOT.0000000000000740

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  2 in total

1.  Discarding Dichotomization: Retrieving Data in the Service of Patient Care.

Authors:  Alan L Hutchison; Adam S Cifu; Anjana A Pillai
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-01-24

2.  Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma.

Authors:  Anjiya Shaikh; Karthik Goli; Nicole E Rich; Jihane N Benhammou; Saira Khaderi; Ruben Hernaez; Vatche G Agopian; John M Vierling; Donghee Kim; Aijaz Ahmed; John A Goss; Abbas Rana; Fasiha Kanwal; George Cholankeril
Journal:  Transplant Direct       Date:  2022-04-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.